Ad
related to: half-life 3
Search results
29 Real-Life Secrets Of The Super-Wealthy, According To People Who Have Worked For Them
BuzzFeed via Yahoo News· 2 days agoThen they decided they may as well build a stable. They now have about eight horses and run an...
For real this time? New rumor suggests Apple is again working with Samsung on foldable screens
Tom's Guide via Yahoo News· 5 days agoDisplay analyst Ross Young suggests a 2024 release of a foldable iPhone. He's usually on the mark...
Independent testing finds toxic chemicals in East Palestine home
The Hill· 7 hours agoAfter officials burned 116,000 gallons of toxic vinyl chloride, releasing a plume over the town, the...
Top 10 Most Iconic Reality TV Stars of All Time
Reality Tea via Yahoo News· 1 day agoThe Texas native became the first American Idol in 2002, scoring a record deal with RCA Records. Since then, she has released 10 studio albums, won 3...
Q1 2024 Talphera Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 13 hours agoSpecifically, participants commented on the nafamostat that safety attributes such as its ultra short half-life, allowing it to be rapidly cleared from ...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 1 day agoDifferentiating From Camzyos Analysts following Cytokinetics stock say differentiating from Bristol...
LADENBURG THALM/SH SH Downgrades Viridian Therapeutics (NASDAQ:VRDN) to Neutral
ETF DAILY NEWS· 3 days agoLADENBURG THALM/SH SH cut shares of Viridian Therapeutics (NASDAQ:VRDN – Free Report) from a buy rating to a neutral rating in a report released on Thursday morning, Marketbeat Ratings reports ...
Downwinders in D.C. lobbying House to pass compensation for radiation exposure
The Santa Fe New Mexican via Yahoo News· 24 hours agoMay 14—More than 30 years after the Cold War ended, the legacy of nuclear testing and the uranium mined to fuel an arms race linger in a bleak half-life ...
Earnings call: Viridian Therapeutics reports robust progress in Q1 2024 By Investing.com
Investing.com· 6 days agoThe company completed enrollment for its Phase 3 trial of the VRDN-001 program for active TED and is...
Spyre shares price target increased on updated preclinical data By Investing.com
Investing.com· 5 days agoThe company has also finished the chemistry, manufacturing, and control (CMC) activities for the...
